Dr. Norman D. Baker, M.D.
Ophthalmology (Ophthalmology Physician)
- Medicare participating
At a glance
- Medical school
- Ohio State University College of Medicine (1982)
- Years since graduation
- 44
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 718
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1982Medical school: Ohio State University College of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
OH license 35.048548 -
Glaucoma Specialist (Ophthalmology) Physician
OH license 35.048548
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Eye Physicians, LLC (39 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 718
- Services billed
- 2,930
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 555 | 338 |
| Exam of visual field with extended testing | 513 | 504 |
| Imaging of optic nerve | 495 | 492 |
| Established patient office or other outpatient visit, 20-29 minutes | 425 | 261 |
| Exam of the internal drainage system of eye | 247 | 235 |
| Ultrasound scan of cornea to determine thickness | 72 | 72 |
| Laser repair to improve eye fluid flow | 53 | 38 |
| New patient office or other outpatient visit, 45-59 minutes | 48 | 48 |
| Revision or repair of operative wound of eye | 48 | 43 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 47 | 27 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Latanoprost Other prescribers in Columbus, OH | 1,767 |
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in Columbus, OH | 1,046 |
| Prednisolone Acetate Other prescribers in Columbus, OH | 638 |
| Brimonidine Tartrate Other prescribers in Columbus, OH | 468 |
| Timolol Maleate Other prescribers in Columbus, OH | 396 |
| Rocklatan (netarsudil mesylat/latanoprost) Other prescribers in Columbus, OH | 222 |
| Dorzolamide Hcl Other prescribers in Columbus, OH | 214 |
| Lumigan (bimatoprost) Other prescribers in Columbus, OH | 199 |
| Combigan (brimonidine tartrate/timolol) Other prescribers in Columbus, OH | 192 |
| Dorzolamide-Timolol (dorzolamide/timolol/pf) | 189 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 43 payments worth $9,288 in total to this clinician.
| Glaukos Corporation | $4,739 |
|---|---|
| W. L. Gore & Associates, Inc. | $4,110 |
| AbbVie Inc. | $101 |
| Dompe US, Inc. | $96.99 |
| Sun Pharmaceutical Industries Inc. | $66.07 |
| Alcon Vision LLC | $49.32 |
| Ani Pharmaceuticals, Inc. | $46.72 |
| Bausch & Lomb Americas Inc. | $36.05 |
| Travel and Lodging | $4,822 |
|---|---|
| Consulting Fee | $2,940 |
| Food and Beverage | $1,526 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Glaukos Corporation Oct 1, 2025 | Travel and Lodging PRESERFLO MicroShunt · Ophthalmology · travel to Aliso Viejo, CA | $1,889 |
| W. L. Gore & Associates, Inc. Jul 11, 2025 | Consulting Fee Product in Development · Devices | $1,680 |
| W. L. Gore & Associates, Inc. Jul 11, 2025 | Consulting Fee Product in Development · Devices | $1,260 |
| Glaukos Corporation Jul 30, 2025 | Travel and Lodging PRESERFLO MicroShunt · Ophthalmology · travel to Aliso Viejo, CA | $1,074 |
| Glaukos Corporation Jul 30, 2025 | Travel and Lodging PRESERFLO MicroShunt · Ophthalmology · travel to Aliso Viejo, CA | $505 |
| W. L. Gore & Associates, Inc. Jul 11, 2025 | Travel and Lodging Product in Development · Devices · travel to Baltimore, MD · in-kind | $410 |
| Glaukos Corporation Jul 30, 2025 | Travel and Lodging PRESERFLO MicroShunt · Ophthalmology · travel to Aliso Viejo, CA | $310 |
| W. L. Gore & Associates, Inc. May 5, 2025 | Travel and Lodging Product in Development · Devices · travel to Baltimore, MD · in-kind | $236 |
| W. L. Gore & Associates, Inc. May 5, 2025 | Travel and Lodging Product in Development · Devices · travel to Baltimore, MD · in-kind | $192 |
| W. L. Gore & Associates, Inc. May 5, 2025 | Travel and Lodging Product in Development · Devices · travel to Baltimore, MD · in-kind | $147 |
All 11 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Glaukos Corporation Oct 1, 2025 | Travel and Lodging PRESERFLO MicroShunt · Ophthalmology · travel to Aliso Viejo, CA | $1,889 |
| Glaukos Corporation Jul 30, 2025 | Travel and Lodging PRESERFLO MicroShunt · Ophthalmology · travel to Aliso Viejo, CA | $1,074 |
| Glaukos Corporation Jul 30, 2025 | Travel and Lodging PRESERFLO MicroShunt · Ophthalmology · travel to Aliso Viejo, CA | $505 |
| Glaukos Corporation Jul 30, 2025 | Travel and Lodging PRESERFLO MicroShunt · Ophthalmology · travel to Aliso Viejo, CA | $310 |
| W. L. Gore & Associates, Inc. Jul 11, 2025 | Consulting Fee Product in Development · Devices | $1,680 |
| W. L. Gore & Associates, Inc. Jul 11, 2025 | Consulting Fee Product in Development · Devices | $1,260 |
| W. L. Gore & Associates, Inc. Jul 11, 2025 | Travel and Lodging Product in Development · Devices · travel to Baltimore, MD · in-kind | $410 |
| W. L. Gore & Associates, Inc. Jul 11, 2025 | Travel and Lodging Product in Development · Devices · travel to Baltimore, MD · in-kind | $58.00 |
| W. L. Gore & Associates, Inc. May 5, 2025 | Travel and Lodging Product in Development · Devices · travel to Baltimore, MD · in-kind | $236 |
| W. L. Gore & Associates, Inc. May 5, 2025 | Travel and Lodging Product in Development · Devices · travel to Baltimore, MD · in-kind | $192 |
| W. L. Gore & Associates, Inc. May 5, 2025 | Travel and Lodging Product in Development · Devices · travel to Baltimore, MD · in-kind | $147 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $5,994 in research payments for these studies, mostly to the institutions running them.
- Prospective, Multicenter Study of PRESERFLOMicroShunt in Subjects with Primary Open-AngleGlaucoma Who Have Failed Previous Medical and SurgicalTreatment
Glaukos Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.